A.I.dvisor tells us that EVO and ACB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and ACB's prices will move in lockstep.
Ticker / NAME | Correlation To EVO | 1D Price Change % |
---|---|---|
EVO | 100% | -1.57% |
Pharmaceuticals: Generic industry (228 stocks) | 4% Poorly correlated | -1.77% |